510(k) K171650

Alere Afinion HbA1c and ACR on Afinion 2 analyzer by Abbott Rapid Diagnostics — Product Code LCP

K171650 is an FDA 510(k) premarket notification submitted by Abbott Rapid Diagnostics for the device "Alere Afinion HbA1c and ACR on Afinion 2 analyzer". The FDA issued a decision of Substantially Equivalent on November 21, 2017. The device falls under product code LCP (Assay, Glycosylated Hemoglobin), a Class II device regulated under 21 CFR 864.7470.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
November 21, 2017
Date Received
June 5, 2017
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Assay, Glycosylated Hemoglobin
Device Class
Class II
Regulation Number
864.7470
Review Panel
HE
Submission Type